| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/09/2007 | CA2162732C Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/04/2007 | WO2007002057A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001975A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | WO2007000234A1 Moxifloxacin therapeutic use for treating immune system functional disturbances |
| 01/04/2007 | WO2006073493A3 Vaccine conjugates comprising a monoclonal antibody binding to human dentritic cells and beta human chronic gonadotropin |
| 01/04/2007 | WO2006068480A3 Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004755 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/04/2007 | US20070004754 Substituted pyrazoles |
| 01/04/2007 | US20070004747 Substituted pyrazoles |
| 01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
| 01/04/2007 | US20070004739 Condensed polycyclic compounds |
| 01/04/2007 | US20070004738 Substituted pyrazoles |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004698 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 01/04/2007 | US20070004678 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes |
| 01/04/2007 | US20070004630 Treating cell proliferation disease; aberrant fetoplacental growth; cancer |
| 01/04/2007 | US20070004022 Industrial fermenting production process of Hirsutella hepiali Chen & Shen of anamorphic fungi related to Chinese Cordyceps Sinensis |
| 01/04/2007 | US20070003645 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 01/04/2007 | US20070003580 Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003569 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis |
| 01/04/2007 | US20070003567 Composition and methods for enhancing immunogenecity of antigens |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003542 Methods for treating diseases or conditions with peptide constructs |
| 01/04/2007 | CA2612760A1 Il-1.beta. binding antibodies and fragments thereof |
| 01/04/2007 | CA2612486A1 Anti-cd71 monoclonal antibodies and uses thereof for treating malignant tumour cells |
| 01/04/2007 | CA2612378A1 Methods and compositions for targeting ifnar2 |
| 01/04/2007 | CA2610959A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | CA2609957A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/03/2007 | EP1739177A1 Antibodies against interferon alpha/beta receptor |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1739081A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
| 01/03/2007 | EP1737958A1 Compositions and methods for inducing anti-tumor immunity |
| 01/03/2007 | EP1737491A2 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS |
| 01/03/2007 | EP1737490A2 Methods of treating autoimmune and inflammatory diseases |
| 01/03/2007 | EP1737487A1 Method for treating autoimmune diseases with antibodies |
| 01/03/2007 | EP1737477A2 Methods of use of probiotic lactobacilli for companion animals |
| 01/03/2007 | EP1737470A2 Hypoallergenic metal amino acid chelates and metal amino acid chelate-containing compositions |
| 01/03/2007 | EP1401872B1 Antigen targeting |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1383514B1 Use of a composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | EP1212071B1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 01/03/2007 | EP1126839B1 Substituted phenethylsulfones and method of reducing tnf-alpha and pde-iv levels |
| 01/03/2007 | EP1071440B1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/03/2007 | EP1044014B9 Agent for treating allergic or hypersensitivity condition |
| 01/03/2007 | EP0726952B1 Receptor on the surface of activated t-cells:acts-4 |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1890252A New class of gamma delta T cells activators and use thereof |
| 01/03/2007 | CN1890218A Tubulin inhibitors |
| 01/03/2007 | CN1889977A Vaccine compositions comprising an interleukin 18 and saponin adjuvant system |
| 01/03/2007 | CN1889958A Methods for suppressing an immune response or a treating a proliferative disorder |
| 01/03/2007 | CN1889945A Use of CHP as an inhibitor of glutathione s-transferases and collagen iv |
| 01/03/2007 | CN1887332A Rehmannia tea granule for strengthening immunity and its compounding process |
| 01/03/2007 | CN1887307A Medicine composition for treating chronic heart failure and hypotension and its prepn and use |
| 01/03/2007 | CN1887297A Medicine composition for delaying senility and raising immunity and its prepn |
| 01/03/2007 | CN1887286A Stable medicine composition of setastine or its salt |
| 01/03/2007 | CN1293192C Immunoregulation polynucleotide and using method thereof |
| 01/03/2007 | CN1293190C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/03/2007 | CN1293090C 9-alpha-substituted estratrienes as selectively active estrogens |
| 01/03/2007 | CN1293081C 28-epirapalogs, preparation method, medicament composition and use |
| 01/03/2007 | CN1293074C Arylindenopyridines with PDE inhibiting activity |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/03/2007 | CN1292797C Immune regulator, immune regulator food and immune regulator fodder |
| 01/03/2007 | CN1292796C Controlled release composition and method of producing the same |
| 01/03/2007 | CN1292772C Chinese traditional medicine for regulating and improving immunologic function |
| 01/03/2007 | CN1292752C Solutions containing epinastine |
| 01/03/2007 | CN1292655C Stable liquid pharmaceutical formulation of IgG antibodies |
| 01/02/2007 | US7157578 4-(2-butylamino)-2, 7-dimethyl-8-(2-methyl-6-methoxypyrid-3-YL) pyrazolo-[1,5-A]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157469 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 01/02/2007 | US7157467 Therapeutic use |
| 01/02/2007 | US7157465 Adenine derivatives |
| 01/02/2007 | US7157464 Substituted piperazines |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157453 Urea substituted imidazoquinolines |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157443 High molecular weight intracellular adhesin antigen; induction immunology response |
| 01/02/2007 | US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157225 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
| 01/02/2007 | US7157092 3-(3-dodecanoyloxytetradecanoylamino) 9-(3-hydroxytetradecanoylamino)-4-oxo-5-azadecan-1,10-diol, 1,10-bis-(dihydrogenphosphate) or its addition salts; treatment of diseases related to a deficiency in the immune defense system or an overexpression of immune responses, cancer therapy |
| 01/02/2007 | US7157087 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | US7157081 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 01/02/2007 | CA2445677C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 01/02/2007 | CA2400226C Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/28/2006 | WO2006138695A1 Triazolopyridine derivatives as cannabinoid receptor 1 antagonists |